The percentage of correctly predicted ‘viral infection’ patients in the test sets was pronouncedly improved (from 63% to 80%) after adding 7 nasal cavity microbiota variables to CRP, whereas the percentage of correctly predicted cases of ‘bacterial infection’ patients was only slightly improved (from 69% to 74%). The gene discussed is CRP; the disease is bacterial infectious disease.